Lista de obras - Piotr Jan Wysocki - Dominio Público Uruguay

3rd international symposium on genetic anticancer agents

artículo científico publicado en 2002

Badania kontrolne po leczeniu w najczęstszych nowotworach litych u dorosłych

artículo científico publicado en 2014

Cancer immunotherapy using cells modified with cytokine genes

artículo científico publicado el 1 de enero de 2003

Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice.

artículo científico publicado en 2006

Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model

scientific article published on 01 June 2015

Combined Neutrophil-to-Lymphocyte and Platelet-Volume-to-Platelet Ratio (NLR and PVPR Score) Represents a Novel Prognostic Factor in Advanced Gastric Cancer Patients

artículo científico publicado en 2021

Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice

artículo científico publicado en 2003

Correlation between insulin resistance and breast elasticity heterogeneity measured by shear wave elastography in premenopausal women - a pilot study

artículo científico publicado en 2011

Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy

artículo científico publicado en 2012

CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice

artículo científico publicado en 2004

European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment

artículo científico publicado en 2020

Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.

artículo científico publicado en 2002

Gene modified tumor vaccines in therapy of malignant melanoma

artículo científico publicado en 2002

Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.

artículo científico publicado en 2010

Guidelines for the prevention and treatment of venous thromboembolism in non-surgically treated cancer patients

artículo científico publicado en 2016

Human cancer gene therapy with cytokine gene-modified cells

artículo científico publicado en 2004

Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccines.

artículo científico publicado en 2011

Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients

artículo científico publicado en 2015

Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice

artículo científico publicado en 2003

Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model.

artículo científico publicado en 2008

Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection

scientific article published on 01 June 2012

New therapeutic options in systemic treatment of advanced cutaneous melanoma

artículo científico

Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.

artículo científico publicado en 2010

Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project

artículo científico publicado en 2018

Polish clinical practice guideline on hyperthermic intraperitoneal chemotherapy (HIPEC) with cytoreductive surgery in peritoneal malignancy treatment

artículo científico publicado en 2014

Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutations

artículo científico publicado en 2008

Progress in the treatment of bone metastases in cancer patients

artículo científico publicado en 2012

Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff

artículo científico publicado en 2014

Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer

artículo científico publicado en 2022

Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents.

artículo científico publicado en 2018

Standardy leczenia żywieniowego w onkologii

artículo científico publicado en 2015

Targeted therapy of hepatocellular cancer.

scientific article published on February 2010

Targeted therapy of renal cell cancer

artículo científico publicado en 2008

The 14th European Immunology Meeting--EFIS 2000. 23-27 September 2000, Poznañ, Poland

artículo científico publicado en 2001

The 15th European Immunology Meeting EFIS 2003

artículo científico publicado en 2003

The 32nd Annual Meeting of German Society of Immunology. 26 - 29 September 2001.

artículo científico publicado en 2002

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial

artículo científico publicado en 2015

Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients

Zasady stosowania dootrzewnowej chemioterapii w hipertermii (HIPEC) w leczeniu nowotworów złośliwych powierzchni otrzewnej w połączeniu z zabiegami cytoredukcyjnymi: zalecenia krajowe

artículo científico publicado en 2015

[Liposomal doxorubicin in patients with breast cancer and concomitant cardiovascular diseases - interdisciplinary expert opinion]

artículo científico publicado en 2016

mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.

scientific article published on April 2009

Lista de obras de Piotr Jan Wysocki

3rd international symposium on genetic anticancer agents

Badania kontrolne po leczeniu w najczęstszych nowotworach litych u dorosłych

Cancer immunotherapy using cells modified with cytokine genes

Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice.

Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model

Combined Neutrophil-to-Lymphocyte and Platelet-Volume-to-Platelet Ratio (NLR and PVPR Score) Represents a Novel Prognostic Factor in Advanced Gastric Cancer Patients

Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice

Correlation between insulin resistance and breast elasticity heterogeneity measured by shear wave elastography in premenopausal women - a pilot study

Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy

CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice

European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment

Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.

Gene modified tumor vaccines in therapy of malignant melanoma

Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.

Guidelines for the prevention and treatment of venous thromboembolism in non-surgically treated cancer patients

Human cancer gene therapy with cytokine gene-modified cells

Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccines.

Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients

Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice

Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model.

Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection

New therapeutic options in systemic treatment of advanced cutaneous melanoma

Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.

Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project

Polish clinical practice guideline on hyperthermic intraperitoneal chemotherapy (HIPEC) with cytoreductive surgery in peritoneal malignancy treatment

Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutations

Progress in the treatment of bone metastases in cancer patients

Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff

Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer

Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents.

Standardy leczenia żywieniowego w onkologii

Targeted therapy of hepatocellular cancer.

Targeted therapy of renal cell cancer

The 14th European Immunology Meeting--EFIS 2000. 23-27 September 2000, Poznañ, Poland

The 15th European Immunology Meeting EFIS 2003

The 32nd Annual Meeting of German Society of Immunology. 26 - 29 September 2001.

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial

Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients

Zasady stosowania dootrzewnowej chemioterapii w hipertermii (HIPEC) w leczeniu nowotworów złośliwych powierzchni otrzewnej w połączeniu z zabiegami cytoredukcyjnymi: zalecenia krajowe

[Liposomal doxorubicin in patients with breast cancer and concomitant cardiovascular diseases - interdisciplinary expert opinion]

mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.